Description: In this third issue of International News in 2022, we feature a contribution by SCOR, a leading reinsurer, highlighting the Actuarial Awards that SCOR presents annually, since 1996, to the best academic work in actuarial science, with annual prizes in several countries throughout the world. We also feature an article by Jessica Leong, FCAS, on barriers that Asian women must overcome to become leaders. Jessica recounts her own experience and how in overcoming some challenges she became the first Asian president of the Casualty Actuarial Society.

Description: In today’s market of post-pandemic consolidation and org chart streamlining, we’ve observed significant changes to actuarial career development and advancement opportunities. But, those changes aren’t occurring in equal measures across the arc of the actuarial career. Our focus is on the impact felt by experienced reinsurance actuaries.

Description: Join this session to awaken your “Inner Actuary” and identify new, state-of-the-art resources and perspectives to discover purpose, direction, and value in embracing and growing the competencies for career and life.

Description: Come learn from a panel of LTC industry professionals as they discuss setting goals for LTC wellness, measuring success of the programs, and integrating them with other LTC process (e.g. assumption setting) in an effort to create sustainable programs.

Description: The 2023 Professionalism in Practice Course will study, discuss and explore the professionalism practice, code of conduct and application of the actuarial profession. Our speakers are seasoned presenters from mainland China. Experts will cover several issues encountered in daily actuarial working environments. Content will include business cases and interactive discussions, which aim to enrich the practical learning experience of attendees. Audience attendance will be limited in order to provide an interactive, collaborative learning experience. Early registration is highly recommended to secure a seat.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Article describes accomplishments as Chair during the year. Four accomplishments are mentioned: i) Actuarial Research Conference ii) Early Career Award, iii) Establishment of Outstanding Educator Award, iv) Push to create surveys from the section containing a reservoir of ideas that can be used for webinars, podcasts, etc.

Description: Article presents a potential role for pension actuaries to help assess the effectiveness of defined contribution plans.

Description: 2021 ImpACT Conference - Session 14A: Credit Risk & Small Diverse Businesses Within Underserved Communities 10.29.21 Recording